Robin R Frey
3PUBLICATIONS
31CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (3)
Sort by Publication Date:
|Oct 04, 2024
BCL-XL-targeting antibody-drug conjugates are active in preclinical models and mitigate on-mechanism toxicity of small-molecule inhibitors.Andrew S Judd, Bhupinder Bawa, Wayne R Buck
|Oct 01, 2024
Discovery of Potent Azetidine-Benzoxazole MerTK Inhibitors with In Vivo Target Engagement.Robin R Frey, Navendu Jana, Jacob V Gorman
|Sep 16, 2024
Discovery of A-910, a Highly Potent and Orally Bioavailable Dual MerTK/Axl-Selective Tyrosine Kinase Inhibitor.Yiyun Yu, Miyeon Jang, Julie Miyashiro
Pageof 1
Frequent Collaborators
1 joint publications
Andrew S Judd
1 joint publications
Bhupinder Bawa
1 joint publications
Wayne R Buck
1 joint publications
Zhi-Fu Tao
1 joint publications
Yingchun Li
1 joint publications
George Doherty
1 joint publications
Kenneth R Durbin
1 joint publications
Deanna Haasch
1 joint publications
Sandra Haman
1 joint publications
Anthony R Haight
